Melissa Palmer, M.D.
Chief Medical Officer

Melissa Palmer, M.D., is an internationally renowned Hepatologist. Prior to joining Gannex, Dr. Palmer was the Head of Liver Disease Clinical Development at Takeda Pharmaceuticals. She has also held senior leadership positions at Shire Pharmaceuticals and Kadmon Corporation, where she was in charge of the global development of NASH and other liver disease programs. Prior to joining the industry, she was a clinical professor at NYU Langone Medical Center and director of Hepatology at NYU Plainview, NY. Since 1991, Dr. Palmer served as a Hepatology consultant to more than 40 biotech and pharmaceutical companies and was a primary investigator on numerous clinical trials in liver disease. Dr. Palmer has authored over 100 publications, abstracts, articles and book chapters, in addition to a best-selling book on liver disease “ Dr. Melissa Palmer’s Guide to Hepatitis and Liver Disease”. She trained in Hepatology at Mount Sinai School of Medicine, where she also received her M.D. degree. She received her Bachelor of Science degree from Columbia University in New York City.